Bibliography

HCC Treatment

Lipiodol® efficacy & safety for improved overall survival in HCC

(1) WHO , cancer today Liver Source: Globocan 2018, http://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf

(2) EASL-EORTC Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma. J. Hepatol. 2018

(3) De Baere t. et al. Circulatory alterations induced by intra-arterial injection of iodized oil emulsions of iodized oil and doxorubicin: experimental study, Radiology,1995; 194: 165-170.

(4) Kan Z. et al. Liver anatomy: microcirculation of the liver, Sem. Intervent. Radiology 2008; 25: 77-85.

(5) Kan Z. et al. Distribution and effect of iodized poppyseed oil in the liver after hepatic artery embolization : experimental study in several animal species, Radiology 1993; 186: 861-866.

(6) Miyayama S. et al. Ultraselective Transcatheter Arterial Chemoembolization with a 2-F Tip Microcatheter for Small Hepatocellular Carcinomas: Relationship Between Local Tumor Recurrence and Visualization of the Portal Vein with Iodized Oil J Vasc Interv Radiol 2007; 18:365–376

(7) Lo C.M. et al. Randomized Controlled Trial of Transarterial Lipiodol Chemoembolization for Unresectable Hepatocellular Carcinoma, Hepatology 2002; 5, 1164-1171.

(8) Llovet J.M. Arterial embolization or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial, The Lancet 2002; 359 : 1734-1739.

(9) US Guidelines: Bruix J. AASLD Practice Guidelines; American Association for Study of the Liver Diseases; Hepatology 2011; Vol. 53, No. 3.

(10) Chinese guidelines 2011 edition, Chin. Clin. Oncol. 2012; 1:10.

(11) Japanese Guidelines: Hepatology Research 2010; 40 (Suppl. 1): 96–112.

(12) Ikeda M. et al. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma : an Asian cooperative study between Japan and Korea 2013; J. VAc. Interv. Radiol.; 24: 490-500.

(13) Guiu B. et al. Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: lipiodol vs. Drug-eluting beads, J. of Hepatol. 2012; 56: 609-617.

(14) De Baere T. et al. Quantification of Tumor Uptake of Iodized Oils and Emulsion of Iodized Oils: Experimental Study Radiology 1996; 201: 731-735.

(15) Nakamura H. et al. Transcatheter Oily Chemoembolization of Hepatocellular Carcinoma Radiology 1989; 170: 783-786.

(16) Chen M. et al. High Dose Iodized Oil Transcatheter Arterial Chemoembolization for Patients with Large Hepatocellular Carcinoma World. gastroenterol. 2002; 8: 74-78.

(17) Shi M. et al. High Roles Played by Chemolipiodolization and Embolization in Chemoembolization for Hepatocellular Carcinoma: Single_blind, Randomized Trial 2012; 105: 59-68.

(18) Georgiades C. et al. Lack of response after initial chemoembolization for hepatocellular carcinoma: Does it predict of subsequent treatment, Radiology 2012 October; 265(1): 115-123.

(19) Terayama N. et al. Accumulation of Iodized Oil Within the Non-Neoplastic Liver Adjacent to Hepatocellular Carcinoma via the Drainage Routes of the Tumor After Transcatheter Arterial Embolization CVIR 2001; 24:383-387

(20) Takayasu K. et al. Comparison of CT Findings with Resected Specimens After Chemoembolization with Iodized Oil for Hepatocellular Carcinoma AJR 2000;175:699–704

Imaging tumors in adults with known HCC

(1) Globocan 2012 Estimated Cancer Incidence, Mortality and Prevalence worldwide, 2012;
http://globocan.iarc.fr/Default.aspx

(2) Europe: EASL-EORTC / Clinical Pratice Guidelines / J. of Hepatology, 2012; 56; 908-943

(3) Rizvi S. et al. Is post-Lipiodol CT Better Than IV Contrast CT Scan for Early Detection of HCC? A Single Liver Transplant Center Experience, Transplant. Proc., 2006; 38: 2993-2995

(4) Gonsalves C.F. et al. Chemoembolization of hepatic malignancy, Abdom. Imaging, 2009; 34:557-65

(5) Pourgholami M. et al. Regression of Novikoff rat hepatocellular carcinoma following locoregional administration of a novel formulation of clofazimine in Lipiodol, Cancer Letters, 2004; 20
7: 37-47

(6) Bruneton JN. et al. Hepatic Intraarterial Lipiodol: Technique, Semiologic Patterns, and Value for Hepatic Tumors, Gas-trointest. Radiol., 1988; 13:45-51

(7) Kim J. et al, Fluoroscopy-guided radiofrequency ablation for small hepatocellular carcinoma: a retrospective comparison with ultrasound-guided ablation, Clin. Radiol., 2015; 70, 1009-101
5

(8) Ngan H. et al. Lipiodol computerized tomography: how sensitive and specific is the technique in the diagnosis of hepa-tocellular carcinoma? Br. J. Radiol., 1990; 63: 771-775


Lymphography

Solution of Visualization For Abnormal Lymphatic System

(1) Edward Wolfgang Lee, et al., Lymphangiography to Treat Postoperative Lymphatic Leakage: A Technical Review Korean J Radiol, 2014;15(6):724-732.

(2) Ryota Kawasaki, et al., Therapeutic Effectiveness of Diagnostic Lymphangiography for Refractory Postoperative Chylothorax and Chylous Ascites: Correlation With Radiologic Findings and Preceding Medical Treatment, AJR, 2013; 201:659–666.

(3) Lee BB, et al., IUA-ISVI consensus for diagnosis guideline of chronic lymphedema of the limbs, Edizioni Minerva Medica, 2014,https://www.minervamedica.it/

(4) Kimberly Levenhagen, et al., Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA, American Physical Therapy Association, Phys Ther, 2017;97: 729–745.

(5) Saebeom Hur, et al., Early Experience in the Management of Postoperative Lymphatic Leakage Using Lipiodol Lymphangiography and Adjunctive Glue Embolization.J VascI nterv Radiol, 2016;27:1177–1186.

(6) Tatjana Gruber-Rouh, et al., Direct lymphangiography as treatment option of lymphatic leakage:Indications, outcomes and role in patient’s management, European Journal of Radiology, 2014;83:2167–2171.

(7) Tetsuya Abe, et al., Therapeutic strategy for chylous leakage after esophagectomy: focusing on lymphangiography using lipiodol, Esophagus, 2016;13:237–244

(8) Sho Kitagawa, et al., Ulrasound-Guided Intranodal Lymphangiography With Ethiodized Oil to Treat Chylous AscitesACG Case Rep J, 2016;3(4):e95.

(9) Jiajia Liu, et al., Ultrasound-guided intranodal lipiodol lymphangiography from the groin is useful for assessment and treatment of post-esophagectomy chylothorax in three cases, International Journal of Surgery Case Reports, 2016;29:103–107.

(10) F. M. Go´mez, et al., Transnodal Lymphangiography in the Diagnosis and Treatment of Genital Lymphedema, Cardiovasc Intervent Radiol, 2012;35:1488–1491

(11) Maxim Itkin, et al., Interventional Treatment of Pulmonary Lymphatic Anomalies,Tech Vasc Interventional Rad, 2016, 19:299-304.

Solution of Visualization & Embolization for Abnormal Lymphatic system

(1) Edward Wolfgang Lee, et al., Lymphangiography to Treat Postoperative Lymphatic Leakage: A Technical Review Korean J Radiol, 2014;15(6):724-732.

(2) Ryota Kawasaki et al., Therapeutic Effectiveness of Diagnostic Lymphangiography for Refractory Postoperative Chylothorax and Chylous Ascites: Correlation With Radiologic Findings and Preceding Medical Treatment, AJR, 2013; 201:659–666.

(3) Lee BB, et al., IUA-ISVI consensus for diagnosis guideline of chronic lymphedema of the limbs, Edizioni Minerva Medica, 2014,https://www.minervamedica.it/

(4) Kimberly Levenhagen, et al.,, Diagnosis of Upper-Quadrant Lymphedema Secondary to Cancer: Clinical Practice Guideline From the Oncology Section of APTA, American Physical Therapy Association. Phys Ther., 2017;97: 729–745.

(5) Saebeom Hur, et al., Early Experience in the Management of Postoperative Lymphatic Leakage Using Lipiodol Lymphangiography and Adjunctive Glue Embolization.J VascI Interv Radiol, 2016;27:1177–1186.

(6) Tatjana Gruber-Rouh, et al., Direct lymphangiography as treatment option of lymphatic leakage:Indications, outcomes and role in patient’s management, European Journal of Radiology, 2014;83:2167–2171.

(7) Tetsuya Abe, et al., Therapeutic strategy for chylous leakage after esophagectomy: focusing on lymphangiography using lipiodol, Esophagus, 2016;13:237–244.

(8) Sho Kitagawa, et al., Ulrasound-Guided Intranodal Lymphangiography With Ethiodized Oil to Treat Chylous Ascites, ACG Case Rep J, 2016;3(4):e95.

(9) F. M. Go´mez, et al., Transnodal Lymphangiography in the Diagnosis and Treatment of Genital Lymphedema, Cardiovasc Intervent Radiol, 2012;35:1488–1491.

(10) Maxim Itkin, et al., Interventional Treatment of Pulmonary Lymphatic Anomalies,Tech Vasc Interventional Rad., 2016;19:299-304.

(11) Yoolim Baek, et al., Lymphatic Leak Occurring After Surgical Lymph NodeDissection: A Preliminary Study Assessing the Feasibility and Outcome of Lymphatic Embolization, Cardiovasc Intervent Radiol, 2016;39:1728–1735.

(12) Kevin C., et al., CT-guided Injection of N-butyl Cyanoacrylate Glue For Treatment of Chylous Leak after Aorto-mesenteric Bypass, Cardiovasc Intervent Radiol, 2014; 37:1103–1106.

(13) Shuji Kariya, et al., Embolization for Thoracic Duct Collateral Leakage in High-Output Chylothorax After Thoracic Surgery, Cardiovasc Intervent Radiol, 2017; 40:55–60.

(14) Tae-Wook Kong, et al., Risk factor analysis for massive lymphatic ascites after laparoscopic retroperitonal lymphadenectomy in gynecologic cancers and treatment using intranodal lymphangiography with glue embolization, J Gynecol Oncol., 2016;Jul;27(4):e44.


VAE

Mastering polymerization time for a better management of Abnormal Vascular Embolization

(1) Takeuchi Y. et al., Guidelines for the use of NBCA in vascular embolization devised by the Committee of Practice Guidelines of the Japanese Society of Interventional Radiology (CGJSIR), 2012 edition, Jpn J Radiol, 2014; 32:500–517.

(2) LEE BB. et al., Consensus Document of the International Union of Angiology (IUA)-2013 Current concepts on the management of arterio-venous malformations, International Angiology, 2013;32(1):11-36.

(3) Seewald S et al., A standardized injection technique and regimen ensures success and safety of N-butyl-2-cyanoacrylate injection for the treatment of gastric fundal varices, Gastrointestinal endoscopy, 2008,68(3): 447-454

(4) American Society for Gastrointestinal Endoscopy. Tissue adhesives: cyanoacrylate glue and fibrin sealant, Gastrointestinal Endoscopy, 2013;78: 2. 209-215.

(5) Madhusudhan KS. et al., Endovascular Embolization of Visceral Artery Pseudoaneurysms Using Modified Injection Technique with N-Butyl Cyanoacrylate Glue, J VascInterv Radiol, 2015;26:1718–1725.

(6) Lo GH. et al., A Prospective, Randomized Trial of Butyl Cyanoacrylate Injection Versus Band Ligation in the Management of Bleeding Gastric Varices, Hepatology,2001; 33( 5), 1060-1064.

(7) Wójcicki P. et al., Epidemiology, Diagnostics and Treatment of Vascular Tumours and Malformations, Adv Clin Exp Med, 2014; 23, 3, 475–484.

(8) Firat M, Treatment of a Giant Orbitofacial Vascular Malformation and Ophthalmic Artery Aneurysms with Intralesion Glue Injections: Case Report, AJNR, 2001;22:1419-1423.

(9) Lowe L.H. et al., Vascular Malformations: Classification and Terminology the Radiologist Needs to Know, Seminars in roentgenology, 2012; 47(2):106-17.

(10) Loffroy R. et al., Endovascular Therapeutic Embolisation: An Overview of Occluding Agents and their Effects on Embolised Tissues, Curr. Vasc. Pharmacol., 2009; 7:250-263.

(11) Kwak H.S. et al, Percutaneous Transportal Sclerotherapy with N-Butyl-2-Cyanoacrylate for Gastric Varices: Technique and Clinical Efficacy, Korean J. Radiol. 2008; 9:526-533.

(12) Van der Bom I.M.J. et al., Target delineation for radiosurgery of a small brain arteriovenous malformation using high-resolution contrast-enhanced cone beam CT, J. NeuroIntervent. Surg,2014; 6:e34.

(13) Jaberi A. et al., Comparison of Clinical Outcomes following Glue versus Polyvinyl Alcohol Portal Vein Embolization for Hypertrophy of the Future Liver Remnant prior to Right Hepatectomy, J. Vasc. Interv. Radiol., 2016; 27:1897–1905.

(14) Pearl M.S. et al., Preoperative Embolization of Primary Spinal Aneurysmal Bone Cysts by Direct Percutaneous Intralesional Injection of n-Butyl-2-Cyanoacrylate, J. Vasc. Interv. Radiol. 2012; 23:841–845.

(15) Bellemann N. et al., Portal vein embolization using a Histoacryl / Lipiodol mixture before right liver resection, Dig. Surg., 2012; 29:236-242.

(16) Singh V. et al., Cyanoacrylate therapy for the treatment of gastric varices: a new method, Journal of Digestive Diseases, 2016;17: 392–398.

(17) Won Y. et al., Clinical efficacy of transcatheter embolization of visceral artery pseudoaneurysms using N-butyl cyanoacrylate (NBCA), Diagnostic and Interventional Imaging, 2015;96: 563–569.

(18) San Norberto E.M. et al., Endovascular embolization of a muscular symptomatic arteriovenous malformation with Glubran 2 acrylic glue, Vascular, 2015; 23, 4, 432–435.

(19) Maxim Itkin, Interventional Treatment of Pulmonary Lymphatic Anomalies, Techniques in Vascular and Interventional Radiology, 2006;19:299-304.

(20) Ohnishi H. et al., Infiltrated Embolization of Meningioma with Dilute Cyanoacrylate Glue, Neurol. Med. Chir. (Tokyo), 2017; 57:44–50.

(21) Urbano J. et al., Sclerosis and varicocele embolization with N-butyl cyanoacrylate: experience in 41 patients, Acta Radiol., 2014; 55(2):179-185.

(22) Gandini R. et al., Transcatheter Embolization of a Large Symptomatic Pelvic Arteriovenous Malformation with Glubran 2 Acrylic Glue, Cardiovasc. Intervent. Radiol. 2008; 31:1030-1033.

(23) Loffroy R. et al., Arterial Embolotherapy for Endoscopically Unmanageable Acute Gastroduodenal Hemorrhage: Predictors of Early Rebleeding, Clin. Gastroenterol. Hepatol, 2009;7:515– 523.

(24) Kanematsu M. et al., Postpartum Hemorrhage in Coagulopathic Patients: Preliminary Experience with Uterine Arterial Embolization with N-Butyl Cyanoacrylate, J. Vasc. Interv. Radiol, 2011; 22:1773-1776.

(25) Simons M.E. et al., Peripheral vascular malformations: diagnosis and percutaneous management, Can. Assoc. Radiol. J., 2001; 52(4):242-251.


VECTORIO®

Vectorio® efficacy & safety for improved cTACE mixing & delivery

(1) Globocan 2012 Estimated Cancer Incidence, Mortality and Prevalence worldwide 2012.

(2) EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. Journal of Hepatology 2012; 56: 908–943.

(3) Miyayama S. et al. Ultraselective Transcatheter Arterial Chemoembolization with a 2-F Tip Microcatheter for Small Hepatocellular Carcinomas: Relationship Between Local Tumor Recurrence and Visualization of the Portal Vein with Iodized Oil. J Vasc Interv Radiol 2007; 18:365–376

(4) Ikeda M. et al. Prospective study of transcatheter arterial chemoembolization for unresectable hepatocellularcarcinoma : an Asian cooperative study between Japan and Korea. J. VAc. Interv. Radiol 2013;24: 490-500.

(5) Thierry de Baere et al., Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion. Cardiovasc Intervent Radiol, 2016;39:334–343.

We use cookies to improve your website experience and to gain insights into our websites’ users and traffic to make it even better. By continuing your navigation on our site without modifying the setting of your cookies, you accept the use of cookies. OKFind out more